Raymond Goodrich

Terumo BCT, Scientific Affairs

Research Area

Biography

Raymond Goodrich has not added Biography.
If you are Raymond Goodrich and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 19	2015

Other Publications

Article	Year
Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion\| PubMed ID: 15157255	2004
Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochemistry and photobiology\| PubMed ID: 15339215	2004
Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to supp... Photochemistry and photobiology\| PubMed ID: 15382964	2004
An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage. Photochemistry and photobiology\| PubMed ID: 15623353	2005
Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Transfusion\| PubMed ID: 15934990	2005
Comparison of computerized formulae for determination of platelet recovery and survival. Transfusion\| PubMed ID: 15987377	2005
Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion\| PubMed ID: 16078923	2005
Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of gluco... Transfusion\| PubMed ID: 16271100	2005
Functional inactivation of white blood cells by Mirasol treatment. Transfusion\| PubMed ID: 16584442	2006
Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox sanguinis\| PubMed ID: 16635070	2006
The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis\| PubMed ID: 16935562	2006
Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Transfusion\| PubMed ID: 16965583	2006
Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion\| PubMed ID: 17302769	2007
Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis\| PubMed ID: 17950672	2007
Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation\| PubMed ID: 17998874	2007
Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfusion medicine reviews\| PubMed ID: 18353253	2008
Reduction of prion infectivity in packed red blood cells. Biochemical and biophysical research communications\| PubMed ID: 18851948	2008
Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons. Transfusion\| PubMed ID: 18954398	2009
A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion\| PubMed ID: 19320867	2009
Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment. Transfusion\| PubMed ID: 19682337	2009
Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates. Transfusion\| PubMed ID: 19694996	2009
Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion\| PubMed ID: 20030791	2010
Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals : journal of the International Association of Biological Standardization\| PubMed ID: 20093041	2010
Defining "adequate" pathogen reduction performance for transfused blood components. Transfusion\| PubMed ID: 20374558	2010
In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion\| PubMed ID: 20456708	2010
White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion\| PubMed ID: 20529002	2010
Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion\| PubMed ID: 20723169	2011
Impact of pathogen reduction technology and storage in platelet additive solutions on platelet function. Transfusion\| PubMed ID: 20977485	2011
Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solutions. Transfusion\| PubMed ID: 21155831	2011
Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis\| PubMed ID: 21251884	2011
In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. Transfusion\| PubMed ID: 21275998	2011
FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety. Transfusion\| PubMed ID: 21392016	2011
Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie\| PubMed ID: 21779202	2011
Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion\| PubMed ID: 21827502	2012
Improving blood safety and patient outcomes with pathogen reduction technology. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis\| PubMed ID: 22078570	2011
Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis\| PubMed ID: 22115607	2012
Preparation of cryoprecipitate from riboflavin and UV light-treated plasma. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis\| PubMed ID: 22342281	2012
Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system. Transfusion\| PubMed ID: 22626525	2013
Fresh whole blood use for hemorrhagic shock: preserving benefit while avoiding complications. Anesthesia and analgesia\| PubMed ID: 22763908	2012
The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection. Blood transfusion = Trasfusione del sangue\| PubMed ID: 22790276	2012
Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood. Transfusion\| PubMed ID: 22803831	2013
In reply to: "Is the SCID mouse model applicable to human acute lung injury?". Transfusion\| PubMed ID: 23140431	2012
A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia. Transfusion\| PubMed ID: 23278371	2013
Development of a riboflavin and ultraviolet light-based device to treat whole blood. Transfusion\| PubMed ID: 23301965	2013
Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion\| PubMed ID: 23301966	2013
Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion\| PubMed ID: 23320495	2013
Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice. Transfusion\| PubMed ID: 23451715	2013
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment. Transfusion\| PubMed ID: 23521225	2013
Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis\| PubMed ID: 23820430	2013
Chemical and biological mechanisms of pathogen reduction technologies. Photochemistry and photobiology\| PubMed ID: 25041351	2014
Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light. Transfusion\| PubMed ID: 25156473	2015
Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method. Transfusion\| PubMed ID: 25355434	2014
The effect of riboflavin and ultraviolet light on the infectivity of arboviruses. Transfusion\| PubMed ID: 25370822	2014
Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage. Shock (Augusta, Ga.)\| PubMed ID: 25423125	2015
Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model. Transfusion\| PubMed ID: 25582335	2015
Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment. Transfusion\| PubMed ID: 25731607	2015